LabCorp has announced that Covance has completed the transaction to acquire GlobalCare, a globally recognized industry leader in patient-centric decentralized clinical trials (DCTs). The acquisition of GlobalCare will expand the Covance DCTs offering into global markets and help meet growing demand for patient-centric trial designs. The COVID-19 pandemic has increased sponsor interest and need for resilient DCT designs as sites restricted on-site visits, eliminating all but the most essential procedures.
Read the full article: Covance Acquires GlobalCare //
Source: https://www.covance.com/GlobalCareClinicalTrials.html